CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of CKD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
6125 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C02901 | BRD-K81053848 | KS-176 | ABCG2 | BCRP inhibitor | Details | |
C02902 | BRD-K66437909 | KT-433 | uricosuric agent | Details | ||
C02903 | BRD-K67566344 | ku-0063794 | MTOR | mTOR inhibitor | Details | |
C02904 | BRD-K25311561 | KU-55933 | ATM|PRKDC | ATM kinase inhibitor | Details | |
C02905 | BRD-K36016295 | KU-60019 | ATM | ATM kinase inhibitor | Details | |
C02906 | BRD-K51337109 | kuromanin | CD38 | ribosyl cyclase inhibitor | Details | |
C02907 | BRD-A38747044 | KU14R | imidazoline receptor antagonist | Details | ||
C02908 | BRD-K21718444 | KW-2449 | ABL1|AURKA|AURKB|FLT3 | Abl kinase inhibitor; Aurora kinase inhibitor; FLT3 inhibitor | Details | |
C02909 | BRD-K41213548 | KW-2478 | HSP inhibitor | Details | ||
C02910 | BRD-A95683721 | KW-3902 | ADORA1|ADORA2A|ADORA2B|ADORA3 | adenosine receptor antagonist | Details | |
C02911 | BRD-K29968218 | KX2-391 | SRC | src inhibitor; tubulin polymerization inhibitor | Details | |
C02912 | BRD-K85872723 | kynurenic-acid | GPR35|GRIN1|GRIN2A|GRIN2B | glutamate receptor antagonist | Details | |
C02913 | BRD-K13302470 | KY02111 | DKK1 | Wnt pathway inhibitor | Details | |
C02914 | BRD-K58568447 | K02288 | BMP1 | bone morphogenic protein inhibitor | Details | |
C02915 | BRD-K12106308 | K145 | SPHK2 | sphingosine kinase inhibitor | Details | |
C02916 | BRD-A86354194 | L-(+)-Rhamnose-Monohydrate | Details | |||
C02917 | BRD-K25125382 | L-alanine | Details | |||
C02918 | BRD-K76811153 | L-Arginine | ARG2|ASL|ASS1|AZIN2|GPRC6A|NOS2|NOS3|SLC7A1|SLC7A3|SLC7A4 | nitric oxide precursor | Details | |
C02919 | BRD-A45419686 | L-Ascorbyl-6-palmitate | Details | |||
C02920 | BRD-K06665116 | L-asparagine | ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3 | Details | ||
C02921 | BRD-K82178523 | L-asparagine-n-hydroxy | Details | |||
C02922 | BRD-K97163964 | L-Aspartic-Acid | ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13 | metallic radical formation stimulant | Details | |
C02923 | BRD-A12237696 | L-Citrulline | ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6 | nitric oxide stimulant | Details | |
C02924 | BRD-K00795468 | L-cysteine | CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3 | Details | ||
C02925 | BRD-A25800195 | L-Cysteinesulfinic-acid | GRM1|GRM5|GSR|HMGCS2|PAPOLA|PRDX2 | glutamate receptor agonist | Details | |
C02926 | BRD-A15397381 | L-Cystine | CTNS|SLC3A1|SLC7A11|SLC7A9 | Details | ||
C02927 | BRD-K26341917 | L-ergothioneine | free radical scavenger | Details | ||
C02928 | BRD-K62309135 | L-glutamic-acid | AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT | glutamate receptor agonist | Details | |
C02929 | BRD-A12454076 | L-Hydroxyproline | Details | |||
C02930 | BRD-K12853841 | L-leucine | BCAT1|BCAT2|LARS|LARS2|LCMT1|LCMT2 | Details | ||
C02931 | BRD-K86016185 | L-lysine | GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4 | serotonin receptor agonist | Details | |
C02932 | BRD-K06502269 | L-methionine | voltage-gated calcium channel ligand | Details | ||
C02933 | BRD-K98151021 | L-mimosine | DBH|EIF5A | dopamine beta hydroxylase inhibitor; eukaryotic translation initiation factor inhibitor | Details | |
C02934 | BRD-K20946707 | L-monomethylarginine | NOS1|NOS2 | nitric oxide synthase inhibitor | Details | |
C02935 | BRD-K33141550 | L-NAME | NOS3 | nitric oxide synthase inhibitor | Details | |
C02936 | BRD-K60036103 | L-NIL | NOS1|NOS2|NOS3 | nitric oxide synthase inhibitor | Details | |
C02937 | BRD-K01666412 | L-proline | EPRS|L3HYPDH|P3H1|P3H2|P3H3|P4HA1|P4HA2|PARS2|PPIA|PPIB|PPIC|PPIF|PPIG|PPIH|PRODH|PROSC|PYCR1|PYCR2|PYCRL|SLC6A14|SLC6A7 | glutamate receptor agonist | Details | |
C02938 | BRD-K92404805 | L-Quisqualic-acid | FOLH1|GRIA2|GRIK1|GRIK2|GRM1|GRM2|GRM3|GRM5|GRM7|GRM8 | glutamate receptor agonist | Details | |
C02939 | BRD-A08715367 | L-Theanine | glutamate receptor antagonist | Details | ||
C02940 | BRD-K75508643 | L-threonine | TARS|TARS2|THNSL1 | Details | ||
C02941 | BRD-A42553870 | L-152804 | NPY5R | neuropeptide receptor antagonist | Details | |
C02942 | BRD-K39733634 | L-161982 | PTGER4 | prostanoid receptor antagonist | Details | |
C02943 | BRD-K98372770 | L-165041 | PPARD | PPAR receptor agonist | Details | |
C02944 | BRD-K18036262 | L-168049 | GCGR | glucagon receptor antagonist | Details | |
C02945 | BRD-K34277641 | L-365260 | CCKAR|CCKBR|KCNQ1 | CCK receptor antagonist | Details | |
C02946 | BRD-A43930669 | L-368899 | AVPR1A|AVPR2|OXTR | oxytocin receptor antagonist | Details | |
C02947 | BRD-K13474508 | L-655,708 | GABRA1|GABRA2|GABRA3|GABRA5|GABRG2 | GABA receptor inverse agonist | Details | |
C02948 | BRD-K89402695 | L-655240 | PTGES | thromboxane receptor antagonist | Details | |
C02949 | BRD-A85472596 | L-670596 | prostanoid receptor antagonist | Details | ||
C02950 | BRD-K74284736 | L-689560 | GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D | glutamate receptor antagonist | Details | |
C02951 | BRD-K28470988 | L-690330 | IMPA1 | inositol monophosphatase inhibitor | Details | |
C02952 | BRD-K83322645 | L-693403 | DRD2|SIGMAR1 | sigma receptor agonist; sigma receptor antagonist | Details | |
C02953 | BRD-K18816859 | L-694247 | HTR1A|HTR1B|HTR1D | serotonin receptor agonist | Details | |
C02954 | BRD-K10176267 | L-701252 | GRIN1 | glutamate receptor antagonist | Details | |
C02955 | BRD-K08109516 | L-701324 | GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D | glutamate receptor antagonist | Details | |
C02956 | BRD-K37952347 | L-732,138 | TACR1|TACR2 | tachykinin antagonist | Details | |
C02957 | BRD-K15791587 | L-733060 | TACR1 | tachykinin antagonist | Details | |
C02958 | BRD-K13211965 | L-741742 | DRD3|DRD4|SCN1A|SCN3A | dopamine receptor antagonist | Details | |
C02959 | BRD-K05528470 | L-745870 | DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR6|HTR7 | dopamine receptor antagonist | Details | |
C02960 | BRD-K39359968 | L-755507 | ADRB1|ADRB2|ADRB3 | adrenergic receptor agonist | Details | |
C02961 | BRD-K30425481 | L-760735 | TACR1 | tachykinin antagonist | Details | |
C02962 | BRD-K10958118 | L-778123 | FNTA|FNTB|PGGT1B | farnesyltransferase inhibitor | Details | |
C02963 | BRD-K43905307 | L-798,106 | PTGER3 | prostanoid receptor antagonist | Details | |
C02964 | BRD-K46647427 | L-838417 | GABRA1|GABRA2|GABRA3|GABRA5 | GABA receptor partial agonist | Details | |
C02965 | BRD-A07440155 | labetalol | ADRA1A|ADRA1B|ADRA1D|ADRB1|ADRB2 | adrenergic receptor antagonist | Details | |
C02966 | BRD-K43586850 | lacidipine | CACNA1C | calcium channel blocker | Details | |
C02967 | BRD-K40787673 | lacitol | osmosis stimulant | Details | ||
C02968 | BRD-K68232650 | lacosamide | SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A | collapsin response mediator protein inhibitor; collapsin response mediator protein stimulant; sodium channel blocker | Details | |
C02969 | BRD-K77258318 | lactulose | laxative | Details | ||
C02970 | BRD-A67516570 | lafutidine | HRH2 | histamine receptor antagonist | Details | |
C02971 | BRD-A02309928 | lamivudine | nucleoside reverse transcriptase inhibitor | Details | ||
C02972 | BRD-K93460210 | lamotrigine | SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A | serotonin receptor antagonist; sodium channel blocker | Details | |
C02973 | BRD-A64242993 | lanatoside-c | cardiac glycoside | Details | ||
C02974 | BRD-K86436199 | landiolol | ADRB1 | adrenergic receptor antagonist | Details | |
C02975 | BRD-A54275602 | lanoconazole | sterol demethylase inhibitor | Details | ||
C02976 | BRD-A49172652 | lansoprazole | ATP4A|ATP4B | ATPase inhibitor | Details | |
C02977 | BRD-K19687926 | lapatinib | EGFR|ERBB2 | EGFR inhibitor | Details | |
C02978 | BRD-A05906449 | lappaconite | sodium channel blocker | Details | ||
C02979 | BRD-K60918217 | laquinimod | CXCL2 | immunosuppressant | Details | |
C02980 | BRD-K48894757 | laropiprant | PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R | prostanoid receptor antagonist | Details | |
C02981 | BRD-A72711497 | lasalocid | bacterial permeability inducer | Details | ||
C02982 | BRD-M93148412 | lasofoxifene | ESR1|ESR2 | selective estrogen receptor modulator (SERM) | Details | |
C02983 | BRD-K10961822 | latanoprost | PTGFR | prostanoid receptor agonist | Details | |
C02984 | BRD-K55703048 | latrepirdine | HRH1|HTR6 | glutamate receptor antagonist | Details | |
C02985 | BRD-K61292460 | latrunculin-b | ACTA1|MKL1|SPIRE2 | actin polymerization inhibitor | Details | |
C02986 | BRD-K67375056 | lauric-acid | GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4 | bacterial permeability inducer | Details | |
C02987 | BRD-K11548689 | lauric-diethanolamide | Details | |||
C02988 | BRD-K35698076 | laurocapram | Details | |||
C02989 | BRD-K51486818 | lazabemide | MAOB | monoamine oxidase inhibitor | Details | |
C02990 | BRD-A49767491 | LB-100 | protein phosphatase inhibitor | Details | ||
C02991 | BRD-K18834913 | LB42708 | farnesyltransferase inhibitor | Details | ||
C02992 | BRD-K08248804 | LCL-161 | BIRC2|XIAP | XIAP inhibitor | Details | |
C02993 | BRD-K20008181 | LCQ908 | DGAT1 | diacylglycerol O acyltransferase inhibitor | Details | |
C02994 | BRD-M31057929 | LCZ696 | angiotensin receptor antagonist | Details | ||
C02995 | BRD-K44715996 | LDC1267 | AXL|MERTK|TYRO3 | protein tyrosine kinase inhibitor | Details | |
C02996 | BRD-K61795638 | LDN-209929 | GSG2 | haspin kinase inhibitor | Details | |
C02997 | BRD-K59831625 | LDN-212854 | ABL1|ACVR1|RIPK2 | bone morphogenic protein inhibitor | Details | |
C02998 | BRD-K51485109 | LDN-27219 | TGM2 | tissue transglutaminase inhibitor | Details | |
C02999 | BRD-K94485812 | LDN-57444 | ubiquitin C-terminal hydrolase inhibitor | Details | ||
C03000 | BRD-K04853698 | LDN193189 | ACVR1|BMPR1A | bone morphogenic protein inhibitor | Details |